GlassScriptPhysician profile
Herman L Maeuser
NPI 1740264613
$4,324.16
in general payments reported to CMS, 2019-2025
44 companies · $770 in 2025
The $770 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $369 · 2020: $126 · 2021: $411 · 2022: $295 · 2023: $1,452 · 2024: $902 · 2025: $770.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,528 · Travel and Lodging: $596.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,527.54 |
| Travel and Lodging | $595.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Clariance, INC. | $595.84 | 2023 | Idys-Alif |
| Atricure, INC. | $390.48 | 2023-2025 | Atriclip Laa Exclusion System, Epi-Sense Guided Coagulation System With Visitrax |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $307.11 | 2019-2025 | Lifevest |
| Novo Nordisk INC | $306.23 | 2024-2025 | Wegovy, Ozempic, Rybelsus |
| Edwards Lifesciences Corporation | $300.74 | 2023-2024 | Sapien 3 Ultra Resilia, Konect Resilia |
| Novartis Pharmaceuticals Corporation | $264.05 | 2020-2025 | |
| Amgen INC. | $192.44 | 2019-2024 | Repatha |
| Janssen Pharmaceuticals, INC | $145.56 | 2019-2024 | Xarelto |
| Organogenesis INC. | $135.22 | 2021-2024 | Puraply, Apligraf |
| W. L. Gore & Associates, INC. | $134.60 | 2025 | Gore Viabahn Vbx Balloon Expandable Endo |
| Boston Scientific Corporation | $133.17 | 2021 | |
| Daiichi Sankyo INC. | $126.14 | 2019-2024 | Injectafer |
| Alnylam Pharmaceuticals INC. | $123.99 | 2022-2025 | Onpattro |
| Cook Medical LLC | $109.53 | 2019 | |
| Philips North America LLC | $99.37 | 2022-2023 |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $87.53 | 2019-2024 | Collagenase Santyl |
| Merck Sharp & Dohme LLC | $82.99 | 2022-2023 | Verquvo |
| Kowa Pharmaceuticals America, INC. | $63.18 | 2019-2021 | |
| Actelion Pharmaceuticals US, INC. | $61.98 | 2025 | Uptravi, Opsumit |
| Altathera Pharmaceuticals LLC | $58.59 | 2022-2024 | Sotalol Hydrochloride |
| Inspire Medical Systems, INC. | $56.36 | 2023-2024 | Inspire |
| Medtronic, INC. | $53.86 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $42.49 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $42.23 | 2019-2023 | |
| Endologix LLC | $35.04 | 2024 | Endocross Device, Torus Stent Graft System |
| Azurity Pharmaceuticals, INC. | $34.58 | 2024 | Edarbi, Edarbyclor |
| Regeneron Healthcare Solutions, INC. | $30.09 | 2019-2023 | Evkeeza |
| Esperion Therapeutics, INC. | $27.83 | 2020-2021 | |
| Polarityte, INC. | $23.86 | 2019 | |
| Abiomed | $23.43 | 2025 | |
| Bsn Medical INC | $21.08 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.73 | 2025 | |
| Cleerly, INC. | $20.16 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Xeris Pharmaceuticals, INC. | $18.96 | 2025 | Keveyis |
| Cvrx, INC. | $18.46 | 2024 | Barostim Neo System |
| Cashflow Solutions, LLC | $18.39 | 2023 | Pcd-52 737a (US) White, Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt |
| Angiodynamics, INC. | $17.17 | 2024 | Auryon Laser System 100-120 Vac |
| United Therapeutics Corporation | $16.74 | 2024 | Tyvaso |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.79 | 2024 | Jardiance |
| Medicomp INC | $14.33 | 2024 | Telepatch Cardiac Monitor |
| Amarin Pharma, INC. | $14.31 | 2019 | |
| Tactile Systems Technology INC | $13.98 | 2023 | Flexitouch Plus, Entre Plus |
| Celularity INC. | $13.00 | 2019 | |
| Arbor Pharmaceuticals, INC. | $12.55 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Herman Maeuser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.